Shopping Cart
- Remove All
- Your shopping cart is currently empty
Immuno modulator-1 (compound 22) effectively suppresses the secretion of TNFα and IL-2 in human peripheral blood mononuclear cells (hPBMC), with IC50 values of 4.7 nM and 26 nM, respectively, and exhibits a 20% inhibitory effect on the hERG potassium channel at a concentration of 3 μM [1].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | Inquiry | 8-10 weeks | |
50 mg | Inquiry | 8-10 weeks |
Description | Immuno modulator-1 (compound 22) effectively suppresses the secretion of TNFα and IL-2 in human peripheral blood mononuclear cells (hPBMC), with IC50 values of 4.7 nM and 26 nM, respectively, and exhibits a 20% inhibitory effect on the hERG potassium channel at a concentration of 3 μM [1]. |
In vitro | Immune modulator-1 (compound 22) inhibits the proliferation of NCI-H929 human myeloma cells with an IC50 of 0.6 nM [1]. |
In vivo | Immuno modulator-1 (compound 22) administered at 1 mg/kg IV and 5 mg/kg PO demonstrated 30% oral bioavailability in male Sprague-Dawley rats [1]. |
Molecular Weight | 582.62 |
Formula | C32H31FN6O4 |
Cas No. | 2757469-20-6 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.